Cargando…

Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts

Patient-derived xenograft (PDX) models have been established as important preclinical cancer models, overcoming some of the limitations associated with the use of cancer cell lines. The utility of prostate cancer PDX models has been limited by an inability to genetically manipulate them in vivo and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Patrick B., Alinezhad, Saeid, Joshi, Andre, Sweeney, Katrina, Tse, Brian W. C., Tevz, Gregor, McPherson, Stephen, Nelson, Colleen C., Williams, Elizabeth D., Vela, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670201/ https://www.ncbi.nlm.nih.gov/pubmed/37999103 http://dx.doi.org/10.3390/curroncol30110683

Ejemplares similares

PV1 down-regulation via shRNA inhibits the growth of pancreatic adenocarcinoma xenografts
por: Deharvengt, Sophie J, et al.
Publicado: (2012)

Construction of shRNA lentiviral vector
por: Song, Hong, et al.
Publicado: (2010)

Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
por: Strezoska, Žaklina, et al.
Publicado: (2012)

Introduction of Mismatches in a Random shRNA-Encoding Library Improves Potency for Phenotypic Selection
por: Wang, Yongping, et al.
Publicado: (2014)

shRNA target prediction informed by comprehensive enquiry (SPICE): a supporting system for high-throughput screening of shRNA library
por: Kamatuka, Kenta, et al.
Publicado: (2016)

Design and cloning strategies for constructing shRNA expression vectors
por: McIntyre, Glen J, et al.
Publicado: (2006)

The effects of stem length and core placement on shRNA activity
por: Mcintyre, Glen J, et al.
Publicado: (2011)

Specific properties of shRNA-mediated CCR5 downregulation that enhance the inhibition of HIV-1 infection in combination with shRNA targeting HIV-1 rev
por: Cardona, Maria E., et al.
Publicado: (2022)

Systemic shRNA mediated knock-down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation
por: Dahlmann, Mathias, et al.
Publicado: (2012)

shRNA‐mediated PPARα knockdown in human glioma stem cells reduces in vitro proliferation and inhibits orthotopic xenograft tumour growth
por: Haynes, Harry R, et al.
Publicado: (2018)

PCR-based generation of shRNA libraries from cDNAs
por: Du, Cheng, et al.
Publicado: (2006)

A comparison of multiple shRNA expression methods for combinatorial RNAi
por: Mcintyre, Glen J, et al.
Publicado: (2011)

Single copy shRNA configuration for ubiquitous gene knockdown in mice
por: Seibler, Jost, et al.
Publicado: (2005)

Optimization and characterization of tRNA-shRNA expression constructs
por: Scherer, Lisa J., et al.
Publicado: (2007)

Optimization of Duplex Stability and Terminal Asymmetry for shRNA Design
por: Matveeva, Olga V., et al.
Publicado: (2010)

Energy profile and secondary structure impact shRNA efficacy
por: Zhou, Hong, et al.
Publicado: (2009)

Production of Transgenic Calves Expressing an shRNA Targeting Myostatin
por: Tessanne, K, et al.
Publicado: (2012)

Improved siRNA/shRNA Functionality by Mismatched Duplex
por: Wu, Haoquan, et al.
Publicado: (2011)

Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)

Using shRNA experiments to validate gene regulatory networks
por: Olsen, Catharina, et al.
Publicado: (2015)

Silencing Human Rb2/p130 with shRNA
por: Leucci, Eleonora, et al.
Publicado: (2007)

Stable expression of shRNA for the control of recombinant adenovirus replication
por: Lana, M.V.G., et al.
Publicado: (2023)

Rapid Creation and Quantitative Monitoring of High Coverage shRNA Libraries
por: Bassik, Michael C., et al.
Publicado: (2009)

Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells
por: Jeet, Varinder, et al.
Publicado: (2014)

Criteria for effective design, construction, and gene knockdown by shRNA vectors
por: Taxman, Debra J, et al.
Publicado: (2006)

Letter to the editor: Does Dicer Expression Affect shRNA processing?
por: Senzer, Neil, et al.
Publicado: (2009)

Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics
por: Vorhies, John S, et al.
Publicado: (2007)

ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth
por: Zheng, Lu, et al.
Publicado: (2012)

Functional Selection of shRNA Loops from Randomized Retroviral Libraries
por: Jensen, Stig Mølgaard Rask, et al.
Publicado: (2012)

Delivery of Therapeutic AGT shRNA by PEG-Bu for Hypertension Therapy
por: Wang, Yu-Qiang, et al.
Publicado: (2013)

The Power Decoder Simulator for the Evaluation of Pooled shRNA Screen Performance
por: Stombaugh, Jesse, et al.
Publicado: (2015)

Protamine nanoparticles for improving shRNA-mediated anti-cancer effects
por: Liu, Ming, et al.
Publicado: (2015)

Generation of a pooled shRNA library for functional genomics screens
por: Papadopoulos, Dimitrios, et al.
Publicado: (2022)

Expression of Chitinase and shRNA Gene Exhibits Resistance to Fungi and Virus
por: Parveen, Samia, et al.
Publicado: (2023)

An RNAi in silico approach to find an optimal shRNA cocktail against HIV-1
por: Méndez-Ortega, María C, et al.
Publicado: (2010)

A Random shRNA-Encoding Library for Phenotypic Selection and Hit-Optimization
por: Wang, Yongping, et al.
Publicado: (2008)

Synthetic Pre-miRNA-Based shRNA as Potent RNAi Triggers
por: Terasawa, Kazuya, et al.
Publicado: (2011)

ShRNA-Targeted Centromere Protein A Inhibits Hepatocellular Carcinoma Growth
por: Li, Yongmei, et al.
Publicado: (2011)

The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA
por: Lisowski, Leszek, et al.
Publicado: (2013)

Characterization of oncogenes on chromosome 21 identified by shRNA-based viability screening
por: Stachorski, Lena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tsn3smq5fmo1u6r0dqtp91c0ma